Lumos Diagnostics Holdings Ltd. ( (AU:LDX) ) just unveiled an update.
Lumos Diagnostics Holdings Ltd, a leader in rapid point-of-care diagnostic technologies, is hosting an investor presentation in Sydney to provide insights into its operations and future strategies. This session aims to engage investors and stakeholders, highlighting Lumos’ commitment to advancing healthcare diagnostics and potentially impacting its market positioning and stakeholder interests.
More about Lumos Diagnostics Holdings Ltd.
Lumos Diagnostics specializes in rapid and complete point-of-care diagnostic test technology to help healthcare professionals more accurately diagnose and manage medical conditions. Lumos offers customized assay development and manufacturing services for POC tests and proprietary digital reader platforms. Lumos also directly develops, manufactures, and commercializes novel Lumos-branded POC tests that target infectious and inflammatory diseases.
YTD Price Performance: -40.0%
Average Trading Volume: 1,344,516
Technical Sentiment Signal: Buy
Current Market Cap: A$17.96M
See more data about LDX stock on TipRanks’ Stock Analysis page.